Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life

Gadisseur, Alain; Kaptein, Ad A.; Breukink-Engbers, W. G. M.; Meer, F. J. M. Van Der; Rosendaal, F.R.

doi:10.1111/j.1538-7836.2004.00659.x

Cited by 96 publications

(95 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Yapılan araştırmalar yaşlı bireylerde yaşanan sorunların ve olumsuz etkilerin (kanama gibi) daha fazla olduğunu göstermesine karşın, [19,24,28,30] bizim araştırmamızda yaşın artması ile pıhtı-önleyici tedaviye ilişkin yaşa-nan sorunların azalmasında, hastalığa özgü yaşanan deneyimlerin, tedaviye uyumun ve kabullenmenin etkili olabileceği düşünüldü. Gadisseur ve ark.…”

Section: Discussionunclassified

“…Gadisseur ve ark. [30] araştırma-larında, gençlerin pıhtı-önleyici tedaviyi yaşlı bireylere göre daha iyi algıladığını saptamışlardır. Almeida ve ark., [28] orta yaştaki bireylerin (40-64 yaş) yaşam kalitesinin genç hastalara ve 65 yaş ve üstü hastalara göre daha iyi olduğunu saptamışlardır.…”

Section: Discussionunclassified

“…etkilenmektedir. [2,19,[27][28][29][30] Pek çok araştırmada hasta memnuniyetini ölçebilmek için hastanın tedaviye uyumunun oldukça önemli olduğu belirtilmiştir. [27,[31][32][33][34] Ancak bu konuda yaşanan karmaşıklık göz önüne alındığında, pıhtı-önler ilaç kullanan bireylerin görüşlerini, deneyimlerini, memnuniyetlerini ölçmenin ve bu sonuçların yaşam kalitesine olan etkilerini incelemenin gereği fark edilmektedir.…”

unclassified

See 2 more Smart Citations

The validity and reliability of Turkish version of the Duke anticoagulation satisfaction scale

Yıldırım¹

2014

Turk Gogus Kalp Dama

View full text Add to dashboard Cite

So nuç:Ölçeğin Türkçe formunun iç tutarlılık güvenirliği, içerik ve yapı geçerliliği açısından geçerli olduğu göste-rildi. Ölçek, pıhtı önler ilaç kullanan hastaların yaşadık-ları sorunları ve bakım gereksinimlerini değerlendirmek için sağlık profesyonellerinin kullanabileceği objektif bir araçtır.Anah tar söz cük ler: Pıhtı önler ilaçlar; hasta memnuniyeti; güve-nirlik ve geçerlik; ölçek; varfarin.Background: This study aims to evaluate the reliability and validity of the Turkish version of Duke Anticoagulation Satisfaction Scale (DASS) which was developed to assess the requirements and perceptions of patients receiving anticoagulant treatment.

show abstract

Section: Discussionunclassified

unclassified

See 1 more Smart Citation

The validity and reliability of Turkish version of the Duke anticoagulation satisfaction scale

Yıldırım¹

2014

Turk Gogus Kalp Dama

View full text Add to dashboard Cite

show abstract

“…45,[55][56][57]64,65,67,73,77 Few trials also provided information on the number of people who were excluded during the recruitment phase because they were incapable of performing self-monitoring. 45,56,61,67,71,73,77,80 It is worth noting that up to 50% of the participants were deemed unsuitable for inclusion. Main reasons for exclusion were old age, anxiety, lack of confidence, inadequate cognitive abilities and poor dexterity.…”

Section: Frequency Of Testingmentioning

confidence: 99%

“…45,55,56,61,62,[64][65][66][67]69,[72][73][74][75][76][77][79][80][81] In most of these trials (11 out of 19), the training was provided in group sessions which lasted for around 1-2 hours 55, 61,62,68,69,72,76,77,81 up to a maximum of 3 hours. 73,74 The training was usually administered by a single member of staff, either a nurse, a practitioner/ physician 45,56,61,64,69 or a pharmacist.…”

Section: Self-monitoringmentioning

confidence: 99%

The clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy, compared with standard UK practice: systematic review and economic evaluation

Sharma

Scotland

Cruickshank

et al. 2015

Health Technol Assess

View full text Add to dashboard Cite

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE) (www.publicationethics.org/).Editorial contact: nihredit@southampton.ac.ukThe full HTA archive is freely available to view online at www.journalslibrary.nihr.ac.uk/hta. Print-on-demand copies can be purchased from the report pages of the NIHR Journals Library website: www.journalslibrary.nihr.ac.uk Criteria for inclusion in the Health Technology Assessment journalReports are published in Health Technology Assessment (HTA) if (1) they have resulted from work for the HTA programme, and (2) they are of a sufficiently high scientific quality as assessed by the reviewers and editors.Reviews in Health Technology Assessment are termed 'systematic' when the account of the search appraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others. HTA programmeThe HTA programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care.The journal is indexed in NHS Evidence via its abstracts included in MEDLINE and its Technology Assessment Reports inform National Institute for Health and Care Excellence (NICE) guidance. HTA research is also an important source of evidence for National Screening Committee (NSC) policy decisions.For more information about the HTA programme please visit the website: http://www.nets.nihr.ac.uk/programmes/hta This reportThe research reported in this issue of the journal was commissioned and funded by the HTA programme on behalf of NICE as project number 13/06/01. The protocol was agreed in June 2013. The assessment report began editorial review in December 2013 and was accepted for publication in March 2014. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors' report and would like to thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report.This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health. If there are verbatim quotations included in this publication the views and opinions expressed by the interviewees are those of the interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, NETSCC, the HTA programme or the Departm...

show abstract

Self-monitoring and self-management of oral anticoagulation

García-Alamino

Ward

Alonso‐Coello³

et al. 2010

Cochrane Database of Systematic Reviews

111

128

View full text Add to dashboard Cite

BACKGROUND: The introduction of portable monitors (pointof-care devices) for the management of patients on oral anticoagulation allows self-testing by the patient at home. Patients who self-test can either adjust their medication according to a predetermined dose-INR schedule (self-management) or they can call a clinic to be told the appropriate dose adjustment (self-monitoring). Several trials of selfmonitoring of oral anticoagulant therapy suggest this may be equal to or better than standard monitoring. OBJECTIVES: To evaluate the effects of self-monitoring or self-management of oral anticoagulant therapy compared to standard monitoring. SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2007, Issue 4), MEDLINE, EMBASE and CINAHL (to November 2007). We checked bibliographies and contacted manufacturers and authors of relevant studies. No language restrictions were applied. SELECTION CRITERIA: Outcomes analysed were thromboembolic events, mortality, major haemorrhage, minor haemorrhage, tests in therapeutic range, frequency of testing, and feasibility of self-monitoring and self-management. DATA COLLECTION AND ANALYSIS: The review authors independently extracted data. We used a fixed-effect model with the Mantzel-Haenzel method to calculate the pooled risk ratio (RR) and Peto's method to verify the results for uncommon outcomes. We examined heterogeneity amongst studies with the Chi 2 and I 2 statistics. MAIN RESULTS: We identified 18 randomized trials (4723 participants). Pooled estimates showed significant reductions in both thromboembolic events (RR 0.50, 95% CI 0.36 to 0.69) and all-cause mortality (RR 0.64, 95% CI 0.46 to 0.89). This reduction in mortality remained significant after the removal of low-quality studies (RR 0.65, 95% CI 0.46 to 0.90). Trials of self-management alone showed significant reductions in thromboembolic events (RR 0.47, 95% CI 0.31 to 0.70) and all-cause mortality (RR 0.55, 95% CI 0.36 to 0.84); self-monitoring did not (thrombotic events RR 0.57, 95% CI 0.32 to 1.00; mortality RR 0.84, 95% CI 0.50 to 1.41). Self-monitoring significantly reduced major haemorrhages (RR 0.56, 95% CI 0.35 to 0.91) whilst self-management did not (RR 1.12, 95% CI 0.78 to 1.61). Twelve trials reported improvements in the percentage of mean INR measurements in the therapeutic range. No heterogeneity was identified in any of these comparisons.

show abstract

Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life

Cited by 96 publications

References 25 publications

The validity and reliability of Turkish version of the Duke anticoagulation satisfaction scale

The validity and reliability of Turkish version of the Duke anticoagulation satisfaction scale

Self-monitoring and self-management of oral anticoagulation

Contact Info

Product

Resources

About